Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Chloramiphene
2. Citrate, Clomiphene
3. Clomid
4. Clomide
5. Clomifen
6. Clomifene
7. Clomiphene
8. Clomiphene Citrate
9. Clomiphene Hydrochloride
10. Clostilbegit
11. Dyneric
12. Gravosan
13. Hydrochloride, Clomiphene
14. Klostilbegit
15. Serophene
1. Clomiphene Citrate
2. 50-41-9
3. Zuclomiphene Citrate
4. Cis-clomiphene Citrate
5. Clomid
6. Zuclomid
7. Clomiphene A Citrate
8. 7619-53-6
9. Clomiphene Citrate Salt
10. Milophene
11. Serophene
12. (z)-clomiphene Citrate
13. Chloramiphene
14. Omifin
15. Rmi 16289
16. Clomivid
17. Clomphid
18. Dyneric
19. Genozym
20. Ikaclomin
21. Clomifene Citrate (serophene)
22. Zuclomiphene (citrate)
23. Uy5x264qzv
24. Mrl 41
25. Nsc-151466
26. 2-(4-(2-chloro-1,2-diphenylvinyl)phenoxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate
27. Nsc 35770
28. Rmi 16312
29. 2-[4-[(z)-2-chloro-1,2-diphenylethenyl]phenoxy]-n,n-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic Acid
30. Ethanamine, 2-(4-((1z)-2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
31. Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-n,n-diethyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
32. Mer-41
33. Mrl-41
34. Unii-uy5x264qzv
35. Nsc 151466
36. Nsc-35770
37. Cas-50-41-9
38. Clomiphene Citrate, Cis-
39. Triethylamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)-, Citrate (1:1), (z)-
40. Mls001332629
41. Mls002207099
42. Schembl223472
43. Spectrum1500196
44. Sgcut00109
45. Chembl1213137
46. Hms501h04
47. Hy-b1617a
48. Hms1920o19
49. Hms2091g06
50. Hms2232d12
51. Pharmakon1600-01500196
52. Amy33425
53. Bcp03057
54. To_000032
55. Ccg-39553
56. Nsc151466
57. Nsc756698
58. S2561
59. Akos005111131
60. Bcp9000541
61. Ds-6814
62. Fd12066
63. Nsc-756698
64. Ncgc00017008-01
65. Ncgc00017008-02
66. Ncgc00017008-03
67. Ncgc00094626-01
68. Ncgc00094626-02
69. Ncgc00164385-01
70. Ac-19685
71. Ac-32011
72. Ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
73. Bcp0726000214
74. Cs-0111663
75. Sw196898-3
76. C08161
77. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate
78. Sr-05000001591
79. Sr-05000001591-1
80. Q27291328
81. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1)
82. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1), (z)-
83. (2)2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate (1:1)
84. 2-(4-[2-chloro-1,2-diphenylethenyl]phenoxy)-n,n-diethylethanamine Citrate Salt
85. {2-[4-(2-chloro-1,2-diphenylvinyl)phenoxy]ethyl}diethylamine 2-hydroxypropane-1,2,3-tricarboxylic Acid Salt
86. 2-({4-[(z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
87. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
88. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Molecular Weight | 598.1 g/mol |
---|---|
Molecular Formula | C32H36ClNO8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 14 |
Exact Mass | 597.2129448 g/mol |
Monoisotopic Mass | 597.2129448 g/mol |
Topological Polar Surface Area | 145 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 708 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Clomid |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 6 | |
---|---|
Drug Name | Clomiphene citrate |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Par Pharm |
3 of 6 | |
---|---|
Drug Name | Serophene |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Emd Serono |
4 of 6 | |
---|---|
Drug Name | Clomid |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Sanofi Aventis Us |
5 of 6 | |
---|---|
Drug Name | Clomiphene citrate |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Par Pharm |
6 of 6 | |
---|---|
Drug Name | Serophene |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Emd Serono |
Fertility Agents, Female
Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
Selective Estrogen Receptor Modulators
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-21
Pay. Date : 2023-11-17
DMF Number : 28947
Submission : 2015-01-20
Status : Active
Type : II
Certificate Number : R1-CEP 2003-251 - Rev 06
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Status : Valid
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29195
Submission : 2015-04-16
Status : Active
Type : II
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32838
Submission : 2018-06-04
Status : Active
Type : II
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3957
Submission : 1980-10-06
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-03-07
Pay. Date : 2024-03-04
DMF Number : 7590
Submission : 1988-07-18
Status : Active
Type : II
Certificate Number : R1-CEP 2003-193 - Rev 04
Issue Date : 2020-08-07
Type : Chemical
Substance Number : 997
Status : Suspended by EDQM G...
NDC Package Code : 17369-817
Start Marketing Date : 1982-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8728
Submission : 1990-09-07
Status : Inactive
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-21
Pay. Date : 2023-11-17
DMF Number : 28947
Submission : 2015-01-20
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32838
Submission : 2018-06-04
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29195
Submission : 2015-04-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-21
Pay. Date : 2013-07-05
DMF Number : 5674
Submission : 1984-12-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8728
Submission : 1990-09-07
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-03-07
Pay. Date : 2024-03-04
DMF Number : 7590
Submission : 1988-07-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3957
Submission : 1980-10-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6336
Submission : 1985-10-25
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Mojo (enclomiphene citrate, pregnenolone and dehydroepiandrosterone) is an oral dissolvable tablet aimed at restoring hormonal balance and naturally increasing testosterone levels in men.
Lead Product(s): Clomiphene Citrate,Pregnenolone,Dehydroepiandrosterone
Therapeutic Area: Psychiatry/Psychology Brand Name: Mojo
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 04, 2024
Lead Product(s) : Clomiphene Citrate,Pregnenolone,Dehydroepiandrosterone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
MangoRx to Launch "MOJO" for Low Testosterone & Hormone Imbalances
Details : Mojo (enclomiphene citrate, pregnenolone and dehydroepiandrosterone) is an oral dissolvable tablet aimed at restoring hormonal balance and naturally increasing testosterone levels in men.
Brand Name : Mojo
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 04, 2024
Regulatory Info :
Registration Country : Sweden
Brand Name : Pergo Time
Dosage Form : TABLET
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Pergotime
Dosage Form : Antic-calc Tablet
Dosage Strength : 50 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Clomid
Dosage Form : Clomiphene 50Mg 10 Units Oral Use
Dosage Strength : 10 CPR 50 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?